1-14 of 14
Steven G. DuBois
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B039: Clinical liquid biopsy testing for detecting actionable genomic alterations in children and young adults with advanced solid tumors

Holly J Roberts, Hannah Comeau, Steven G Dubois, Katerina Hoskova, Douglas I Lin, Brian D Crompton, Katherine A Janeway, David S Shulman
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (21_Supplement): B039.
https://doi.org/10.1158/1557-3265.LIQBIOP24-B039
Published: 13 November 2024
View article titled, Abstract B039: Clinical liquid biopsy testing for detecting actionable genomic alterations in children and young adults with advanced solid tumors
Journal Articles

Report of the First International Symposium on NUT Carcinoma

Christopher A. French, Michael L. Cheng, Glenn J. Hanna, Steven G. DuBois, Nicole G. Chau, Christine L. Hann, Simone Storck, Ravi Salgia, Matteo Trucco, Jennifer Tseng, Anastasios Stathis, Richard Piekarz, Ulrich M. Lauer, Christophe Massard, Kelly Bennett, Shodeinde Coker, Ulrike Tontsch-Grunt, Martin L. Sos, Sida Liao, Catherine J. Wu, Kornelia Polyak, Sarina A. Piha-Paul, Geoffrey I. Shapiro
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (12): 2493–2505.
https://doi.org/10.1158/1078-0432.CCR-22-0591
Published: 13 June 2022
View article titled, Report of the First International Symposium on NUT Carcinoma
Open the PDF for Report of the First International Symposium on NUT Carcinoma in another window
Journal Articles

Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers

Suzanne J. Forrest, Alyaa Al-Ibraheemi, Duong Doan, Abigail Ward, Catherine M. Clinton, Juan Putra, R. Seth Pinches, Cigall Kadoch, Susan N. Chi, Steven G. DuBois, Patrick J. Leavey, Nicole R. LeBoeuf, Elizabeth Mullen, Natalie Collins, Alanna J. Church, Katherine A. Janeway
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (12): 2882–2890.
https://doi.org/10.1158/1078-0432.CCR-19-3089
Published: 15 June 2020
View article titled, Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers
Open the PDF for Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers in another window
Includes: Supplementary data
Journal Articles

Abstract A61: Evaluation of ctDNA in children with relapsed or refractory neuroblastoma treated with 131I-MIBG

David S. Shulman, Kelly Klega, Araz Marachelian, Katherine K. Matthay, Julie R. Park, M. Meaghan Granger, Steven G. DuBois, Brian D. Crompton
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11_Supplement): A61.
https://doi.org/10.1158/1557-3265.LiqBiop20-A61
Published: 01 June 2020
View article titled, Abstract A61: Evaluation of ctDNA in children with relapsed or refractory neuroblastoma treated with 131I-MIBG
Journal Articles

Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study

Michael J. Burke, Rumen Kostadinov, Richard Sposto, Lia Gore, Shannon M. Kelley, Cara Rabik, Jane B. Trepel, Min-Jung Lee, Akira Yuno, Sunmin Lee, Deepa Bhojwani, Sima Jeha, Bill H. Chang, Maria Luisa Sulis, Michelle L. Hermiston, Paul Gaynon, Van Huynh, Anupam Verma, Rebecca Gardner, Kenneth M. Heym, Robyn M. Dennis, David S. Ziegler, Theodore W. Laetsch, Javier E. Oesterheld, Steven G. Dubois, Jessica A. Pollard, Julia Glade-Bender, Todd M. Cooper, Joel A. Kaplan, Midhat S. Farooqi, Byunggil Yoo, Erin Guest, Alan S. Wayne, Patrick A. Brown
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (10): 2297–2307.
https://doi.org/10.1158/1078-0432.CCR-19-1251
Published: 15 May 2020
View article titled, Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study
Open the PDF for Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study in another window
Includes: Supplementary data
Journal Articles

Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

Steven G. DuBois, Yael P. Mosse, Elizabeth Fox, Rachel A. Kudgus, Joel M. Reid, Renee McGovern, Susan Groshen, Rochelle Bagatell, John M. Maris, Clare J. Twist, Kelly Goldsmith, M. Meaghan Granger, Brian Weiss, Julie R. Park, Margaret E. Macy, Susan L. Cohn, Greg Yanik, Lars M. Wagner, Randall Hawkins, Jesse Courtier, Hollie Lai, Fariba Goodarzian, Hiroyuki Shimada, Najee Boucher, Scarlett Czarnecki, Chunqiao Luo, Denice Tsao-Wei, Katherine K. Matthay, Araz Marachelian
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (24): 6142–6149.
https://doi.org/10.1158/1078-0432.CCR-18-1381
Published: 13 December 2018
View article titled, Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma
Open the PDF for Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors

Birgit Geoerger, Franck Bourdeaut, Steven G. DuBois, Matthias Fischer, James I. Geller, Nicholas G. Gottardo, Aurélien Marabelle, Andrew D.J. Pearson, Shakeel Modak, Thomas Cash, Giles W. Robinson, Marlyane Motta, Alessandro Matano, Suraj G. Bhansali, Jason R. Dobson, Sudha Parasuraman, Susan N. Chi
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (10): 2433–2441.
https://doi.org/10.1158/1078-0432.CCR-16-2898
Published: 14 May 2017
View article titled, A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors
Open the PDF for A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors

Amy L. Sherborne, Vincent Lavergne, Katharine Yu, Leah Lee, Philip R. Davidson, Tali Mazor, Ivan V. Smirnoff, Andrew E. Horvai, Mignon Loh, Steven G. DuBois, Robert E. Goldsby, Joseph P. Neglia, Sue Hammond, Leslie L. Robison, Rosanna Wustrack, Joseph F. Costello, Alice O. Nakamura, Kevin M. Shannon, Smita Bhatia, Jean L. Nakamura
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (7): 1852–1861.
https://doi.org/10.1158/1078-0432.CCR-16-0610
Published: 02 April 2017
View article titled, Somatic and Germline <em>TP53</em> Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors
Open the PDF for Somatic and Germline <em>TP53</em> Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors in another window
Includes: Supplementary data
Journal Articles

A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study

Todd M. Cooper, Jeannette Cassar, Elena Eckroth, Jemily Malvar, Richard Sposto, Paul Gaynon, Bill H. Chang, Lia Gore, Keith August, Jessica A. Pollard, Steven G. DuBois, Lewis B. Silverman, Javier Oesterheld, Guy Gammon, Daniel Magoon, Colleen Annesley, Patrick A. Brown
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (16): 4014–4022.
https://doi.org/10.1158/1078-0432.CCR-15-1998
Published: 14 August 2016
View article titled, A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia &amp; Lymphoma (TACL) Study
Open the PDF for A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study in another window
Includes: Supplementary data
Journal Articles

Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group

Kieuhoa T. Vo, Jeremy V. Edwards, C. Lorrie Epling, Elizabeth Sinclair, Douglas S. Hawkins, Holcombe E. Grier, Katherine A. Janeway, Phillip Barnette, Elizabeth McIlvaine, Mark D. Krailo, Donald A. Barkauskas, Katherine K. Matthay, Richard B. Womer, Richard G. Gorlick, Stephen L. Lessnick, Crystal L. Mackall, Steven G. DuBois
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (14): 3643–3650.
https://doi.org/10.1158/1078-0432.CCR-15-2516
Published: 14 July 2016
View article titled, Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group
Open the PDF for Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group in another window
Includes: Supplementary data
Journal Articles

Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma

Steven G. DuBois, Susan Groshen, Julie R. Park, Daphne A. Haas-Kogan, Xiaodong Yang, Ethan Geier, Eugene Chen, Kathy Giacomini, Brian Weiss, Susan L. Cohn, M. Meaghan Granger, Gregory A. Yanik, Randall Hawkins, Jesse Courtier, Hollie Jackson, Fariba Goodarzian, Hiroyuki Shimada, Scarlett Czarnecki, Denice Tsao-Wei, Judith G. Villablanca, Araz Marachelian, Katherine K. Matthay
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (12): 2715–2721.
https://doi.org/10.1158/1078-0432.CCR-14-3240
Published: 14 June 2015
View article titled, Phase I Study of Vorinostat as a Radiation Sensitizer with <sup>131</sup>I-Metaiodobenzylguanidine (<sup>131</sup>I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma
Open the PDF for Phase I Study of Vorinostat as a Radiation Sensitizer with <sup>131</sup>I-Metaiodobenzylguanidine (<sup>131</sup>I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial

Steven G. DuBois, Louis Chesler, Susan Groshen, Randall Hawkins, Fariba Goodarzian, Hiroyuki Shimada, Greg Yanik, Michael Tagen, Clinton Stewart, Yael P. Mosse, John M. Maris, Denice Tsao-Wei, Araz Marachelian, Judith G. Villablanca, Katherine K. Matthay
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (9): 2679–2686.
https://doi.org/10.1158/1078-0432.CCR-11-3201
Published: 30 April 2012
View article titled, Phase I Study of Vincristine, Irinotecan, and <sup>131</sup>I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial
Open the PDF for Phase I Study of Vincristine, Irinotecan, and <sup>131</sup>I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial in another window
Includes: Supplementary data
Journal Articles

Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study

Steven G. DuBois, Suzanne Shusterman, Ashish M. Ingle, Charlotte H. Ahern, Joel M. Reid, Bing Wu, Sylvain Baruchel, Julia Glade-Bender, Percy Ivy, Holcombe E. Grier, Peter C. Adamson, Susan M. Blaney
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (15): 5113–5122.
https://doi.org/10.1158/1078-0432.CCR-11-0237
Published: 31 July 2011
View article titled, Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study
Open the PDF for Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study in another window
Journal Articles

Vorinostat Increases Expression of Functional Norepinephrine Transporter in Neuroblastoma In Vitro and In Vivo Model Systems

Swati S. More, Melissa Itsara, Xiaodong Yang, Ethan G. Geier, Michelle K. Tadano, Youngho Seo, Henry F. VanBrocklin, William A. Weiss, Sabine Mueller, Daphne A. Haas-Kogan, Steven G. DuBois, Katherine K. Matthay, Kathleen M. Giacomini
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (8): 2339–2349.
https://doi.org/10.1158/1078-0432.CCR-10-2949
Published: 14 April 2011
View article titled, Vorinostat Increases Expression of Functional Norepinephrine Transporter in Neuroblastoma <em>In Vitro</em> and <em>In Vivo</em> Model Systems
Open the PDF for Vorinostat Increases Expression of Functional Norepinephrine Transporter in Neuroblastoma <em>In Vitro</em> and <em>In Vivo</em> Model Systems in another window
Includes: Supplementary data